Merrill B J, Holm C
Department of Pharmacology, Center for Molecular Genetics, University of California, San Diego, La Jolla 92093-0651, USA.
Genetics. 1998 Feb;148(2):611-24. doi: 10.1093/genetics/148.2.611.
To identify in vivo pathways that compensate for impaired proliferating cell nuclear antigen (PCNA or Pol30p in yeast) activity, we performed a synthetic lethal screen with the yeast pol30-104 mutation. We identified nine mutations that display synthetic lethality with pol30-104; three mutations affected the structural gene for the large subunit of replication factor C (rfc1), which loads PCNA onto DNA, and six mutations affected three members of the RAD52 epistasis group for DNA recombinational repair (rad50, rad52 and rad57). We also found that pol30-104 displayed synthetic lethality with mutations in other members of the RAD52 epistasis group (rad51 and rad54), but not with mutations in members of the RAD3 nor the RAD6 epistasis group. Analysis of nine different pol30 mutations shows that the requirement for the RAD52 pathway is correlated with a DNA replication defect but not with the relative DNA repair defect caused by pol30 mutations. In addition, mutants that require RAD52 for viability (pol30-100, pol30-104, rfc1-1 and rth1delta) accumulate small single-stranded DNA fragments during DNA replication in vivo. Taken together, these data suggest that the RAD52 pathway is required when there are defects in the maturation of Okazaki fragments.
为了确定在体内能够补偿增殖细胞核抗原(酵母中为PCNA或Pol30p)活性受损的途径,我们利用酵母pol30 - 104突变进行了合成致死筛选。我们鉴定出九个与pol30 - 104表现出合成致死性的突变;三个突变影响复制因子C(Rfc1)大亚基的结构基因,Rfc1负责将PCNA加载到DNA上,六个突变影响DNA重组修复的RAD52上位性组的三个成员(rad50、rad52和rad57)。我们还发现pol30 - 104与RAD52上位性组的其他成员(rad51和rad54)的突变表现出合成致死性,但与RAD3或RAD6上位性组的成员突变没有这种现象。对九个不同的pol30突变的分析表明,对RAD52途径的需求与DNA复制缺陷相关,而与pol30突变引起的相对DNA修复缺陷无关。此外,在体内DNA复制过程中,需要RAD52才能存活的突变体(pol30 - 100、pol30 - 104、rfc1 - 1和rth1delta)会积累小的单链DNA片段。综上所述,这些数据表明当冈崎片段成熟存在缺陷时,需要RAD52途径。